You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 6, June 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

One-Year Follow-up of Infants With Abstinence-Associated Seizures

Tatiana M. Doberczak, MD; Stefan Shanzer, MD; Rhoda Cutler, PhD; Ruby T. Senie, PhD; Joanna A. Loucopoulos, MD; Stephen R. Kandall, MD

Arch Neurol. 1988;45(6):649-653.


Abstract

• Fourteen infants with neonatal abstinence-associated seizures were assessed neurodevelopmentally during the first year of life. Despite abnormal neurologic examination results in eight of 12 infants at 2 to 4 months of age, nine of 12 infants had normal neurologic examination results at follow-up (two infants were unavailable for follow-up; one infant died of acquired immunodeficiency syndrome). Nine neonatal electroencephalograms were abnormal; seven of eight of these abnormal tracings normalized during the follow-up period. Bayley developmental scores remained normal during the first year of life and did not differ from either passively addicted infants without seizures or from published population norms. This short-term favorable prognosis for abstinence-associated seizures differs from that associated with neonatal seizures due to other causes. This observed improvement in neurologic function may be based on replenishment of neurotransmitters following transient depletion in the neonatal period.



Author Affiliations

From the Departments of Pediatrics (Drs Doberczak, Loucopoulos, and Kandall), Neurology (Dr Shanzer), Psychiatry (Dr Cutler), and Community Medicine (Dr Senie), Beth Israel Medical Center, Mount Sinai School of Medicine, New York.


Footnotes

Accepted for publication Feb 8, 1988.

Presented in part at the Greater New York Conference on Perinatal Research, New York, Nov 21, 1986.

Reprint requests to Division of Neonatology, Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003 (Dr Kandall).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neonatal Drug Withdrawal.
Committee on Drugs
Pediatrics 1998;101:1079-1079.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.